Zymo Research Launches Research Grant to Empower Mapping the RNome
Irvine, CA (Apr 10, 2025) – Zymo Research is proud to introduce the RNome Disruptive Research Grant, that is designed to empower scientists mapping the RNome and advance our overall understanding of RNA. Aligned with the Human RNome Project’s vision, this grant supports researchers exploring the complexities of RNA across all organisms. By fostering collaboration and innovation, Zymo Research aims to accelerate scientific breakthroughs with diagnostic and therapeutic potential.
Grant Award
Zymo Research is offering $5,000 USD to five (5) grantees towards their innovative RNA technologies, spanning sample collection, extraction, and library preparation, plus an exclusive technology consultation with their scientists.
Eligibility and Deadline
This grant is open to researchers worldwide. Proposals must be original and align with the grant’s mission of uncovering the complexities of RNA for all organisms. Applications are due by June 10, 2025, with winners announced by July 31, 2025.
For application and submission details, please visit the RNome Grant Page.
-------
About Zymo Research Corp.
Zymo Research, a privately owned biotech company founded in 1994, is a global leader in molecular tools for life sciences. Driven by the principle "The Beauty of Science is to Make Things Simple," Zymo Research is dedicated to developing innovative solutions that address complex scientific challenges.
Zymo Research offers a comprehensive range of technologies, including sample collection reagents and devices, DNA/RNA purification kits, and NGS library preparation kits, as well as microbiomics, transcriptomics, epigenomics, and genomics sequencing services.
In addition to providing cutting-edge research tools, Zymo Research is committed to sustainability. By developing environmentally friendly solutions, the company strives to reduce waste and contribute to a more sustainable future through scientific innovation.
For more information, please visit www.zymoresearch.com and follow on Facebook, LinkedIn, X (Twitter), and Instagram.